BCMA-CD19

Health

Innovative Use of BCMA-CD19 Bispecific CAR T Cells in Treating Relapsed/Refractory CIDP

June 24, 2024

0 141

$Innovative Use of BCMA-CD19 Bispecific CAR T Cells in Treating Relapsed/Refractory CIDP$

A groundbreaking study BCMA-CD19 led by Professor Junnian Zheng and Ming Shi from the Cancer Institute of Xuzhou Medical University,…